Works matching IS 00099236 AND DT 2000 AND VI 68 AND IP 5

Results: 12

Effect of angiotensin II infusion with and without angiotensin II type 1 receptor blockade on nitric oxide metabolism and endothelin in human beings: A placebo-controlled study in healthy volunteers.
Published in:
Clinical Pharmacology & Therapeutics, 2000, v. 68, n. 5, p. 501, doi. 10.1067/mcp.2000.111182
By:
- Gossmann, Jan;
- Burkhardt, Ralf;
- Harder, Sebastian;
- Lenz, Tomas;
- Sedlmeyer, Annette;
- Klinkhardt, Ute;
- Haak, Thomas;
- Geiger, Helmut;
- Scheuermann, Ernst-Heinrich
Publication type:
Article
Grapefruit-felodipine interaction: Effect of unprocessed fruit and probable active ingredients*.
Published in:
Clinical Pharmacology & Therapeutics, 2000, v. 68, n. 5, p. 468, doi. 10.1067/mcp.2000.110774
By:
- Bailey, David G.;
- Dresser, George K.;
- Kreeft, John H.;
- Munoz, Claudio;
- Freeman, David J.;
- Bend, John R.
Publication type:
Article
Gender-dependent racial difference in disposition of cyclosporine among healthy African American and white volunteers*.
Published in:
Clinical Pharmacology & Therapeutics, 2000, v. 68, n. 5, p. 478, doi. 10.1067/mcp.2000.111255
By:
- Min, David I.;
- Lee, Miyoung;
- Ku, Yi-Min;
- Flanigan, Michael
Publication type:
Article
The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effect*.
Published in:
Clinical Pharmacology & Therapeutics, 2000, v. 68, n. 5, p. 487, doi. 10.1067/mcp.2000.110772
By:
- Varis, Tiina;
- Kivistö, Kari T.;
- Backman, Janne T.;
- Neuvonen, Pertti J.
Publication type:
Article
Rifampin decreases the plasma concentrations and effects of repaglinide*.
Published in:
Clinical Pharmacology & Therapeutics, 2000, v. 68, n. 5, p. 495, doi. 10.1067/mcp.2000.111183
By:
- Niemi, Mikko;
- Backman, Janne T.;
- Neuvonen, Mikko;
- Neuvonen, Pertti J.;
- Kivistö, Kari T.
Publication type:
Article
Do caffeine-containing analgesics promote dependence? A review and evaluation.
Published in:
Clinical Pharmacology & Therapeutics, 2000, v. 68, n. 5, p. 457, doi. 10.1067/mcp.2000.110974
By:
- Feinstein, Alvan R.;
- Heinemann, Lothar A. J.;
- Dalessio, Donald;
- Fox, Johannes M.;
- Goldstein, Jerome;
- Haag, Gunther;
- Ladewig, Dieter;
- O'Brien, Charles P.
Publication type:
Article
Pharmacokinetic analysis of bioequivalence trials: Implications for sex-related issues in clinical pharmacology and biopharmaceutics.
Published in:
Clinical Pharmacology & Therapeutics, 2000, v. 68, n. 5, p. 510, doi. 10.1067/mcp.2000.111184
By:
- Chen, Mei-Ling;
- Lee, Sue-Chih;
- Ng, Moh-Jee;
- Schuirmann, Donald J.;
- Lesko, Lawrence J.;
- Williams, Roger L.
Publication type:
Article
Myocardial efficiency during levosimendan infusion in congestive heart failure*.
Published in:
Clinical Pharmacology & Therapeutics, 2000, v. 68, n. 5, p. 522, doi. 10.1067/mcp.2000.110972
By:
- Ukkonen, Heikki;
- Saraste, Markku;
- Akkila, Juha;
- Knuuti, Juhani;
- Karanko, Meri;
- Iida, Hidehiro;
- Lehikoinen, Pertti;
- Någren, Kjell;
- Lehtonen, Lasse;
- Voipio-Pulkki, Liisa-Maria
Publication type:
Article
Clinical impact of cyclosporine cellular pharmacodynamics in minimal change nephrotic syndrome*.
Published in:
Clinical Pharmacology & Therapeutics, 2000, v. 68, n. 5, p. 532, doi. 10.1067/mcp.2000.110773
By:
- Hirano, Toshihiko;
- Akashi, Takao;
- Keira, Takayuki;
- Oka, Kitaro;
- Ihoya, Noriko;
- Yoshida, Masaharu
Publication type:
Article
Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children*.
Published in:
Clinical Pharmacology & Therapeutics, 2000, v. 68, n. 5, p. 541, doi. 10.1067/mcp.2000.110977
By:
- Takahashi, Harumi;
- Ishikawa, Shiro;
- Nomoto, Shinichi;
- Nishigaki, Yoshiyuki;
- Ando, Fumitaka;
- Kashima, Toshitaka;
- Kimura, Sosuke;
- Kanamori, Madoka;
- Echizen, Hirotoshi
Publication type:
Article
Pegylated interferon-α2b: Pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data*.
Published in:
Clinical Pharmacology & Therapeutics, 2000, v. 68, n. 5, p. 556, doi. 10.1067/mcp.2000.110973
By:
- Glue, Paul;
- Fang, Jane W.S.;
- Rouzier-Panis, Regine;
- Raffanel, Claude;
- Sabo, Ron;
- Gupta, Samir K.;
- Salfi, Margaret;
- Jacobs, Sheila
Publication type:
Article
Prediction of the outcome of a phase 3 clinical trial of an antischizophrenic agent (quetiapine fumarate) by simulation with a population pharmacokinetic and pharmacodynamic model.
Published in:
Clinical Pharmacology & Therapeutics, 2000, v. 68, n. 5, p. 568, doi. 10.1067/mcp.2000.110975
By:
- Kimko, Hui C.;
- Reele, Stots S. B.;
- Holford, Nicholas H. G.;
- Peck, Carl C.
Publication type:
Article

Works matching IS 00099236 AND DT 2000 AND VI 68 AND IP 5

Effect of angiotensin II infusion with and without angiotensin II type 1 receptor blockade on nitric oxide metabolism and endothelin in human beings: A placebo-controlled study in healthy volunteers.

Grapefruit-felodipine interaction: Effect of unprocessed fruit and probable active ingredients<sup>*</sup>.

Gender-dependent racial difference in disposition of cyclosporine among healthy African American and white volunteers<sup>*</sup>.

The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effect<sup>*</sup>.

Rifampin decreases the plasma concentrations and effects of repaglinide<sup>*</sup>.

Do caffeine-containing analgesics promote dependence? A review and evaluation.

Pharmacokinetic analysis of bioequivalence trials: Implications for sex-related issues in clinical pharmacology and biopharmaceutics.

Myocardial efficiency during levosimendan infusion in congestive heart failure<sup>*</sup>.

Clinical impact of cyclosporine cellular pharmacodynamics in minimal change nephrotic syndrome<sup>*</sup>.

Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children<sup>*</sup>.

Pegylated interferon-α2b: Pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data<sup>*</sup>.

Prediction of the outcome of a phase 3 clinical trial of an antischizophrenic agent (quetiapine fumarate) by simulation with a population pharmacokinetic and pharmacodynamic model.